Professional guideline
Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II–IVA nasopharyngeal carcinoma: CSCO and ASCO guideline
Chen YP, Ismaila N, Chua MLK, et al.
DoseLab summary
Evidence-based guideline from the Chinese Society of Clinical Oncology and ASCO on chemotherapy with definitive radiotherapy for stage II–IVA nasopharyngeal carcinoma. Citation checked against Crossref; content not yet reviewed by DoseLab.
Why this is useful
Joint CSCO/ASCO guideline on when to add concurrent, induction and adjuvant chemotherapy to radiotherapy for nasopharyngeal carcinoma.
Reference details
- Title
- Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II–IVA nasopharyngeal carcinoma: CSCO and ASCO guideline
- Authors / organization
- Chen YP, Ismaila N, Chua MLK, et al.
- Publication / protocol
- J Clin Oncol. 2021;39(7):840–859
- Version
- Pending verification
- Year
- 2021
- DOI
- 10.1200/JCO.20.03237
- Disease sites
- Head & Neck
- Topics
- Head & Neck, Nasopharynx, Chemoradiation, Guideline
- Fractionation context
- Pending verification
- Last reviewed by DoseLab
- Pending verification